Lataa...

The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients

BACKGROUND: There has been debate on the use of angiotensin-converting enzyme‑2 (ACE2) expression mediating pharmacotherapy in COVID-19 infected patients. Although it has been suggested that these drugs might lead to a higher susceptibility and severity of COVID-19 infection, experimental data sugge...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neth Heart J
Päätekijät: van Kimmenade, R. R. J., Belfroid, E., Hoogervorst-Schilp, J., Siebelink, H. J., Janssen, C. W., Pinto, Y.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Bohn Stafleu van Loghum 2021
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8050813/
https://ncbi.nlm.nih.gov/pubmed/33860910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-021-01573-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!